Institutional investors hold a majority ownership of CELG through the 84.35% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2013, these large investors purchased a net $5.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MARSICO CAPITAL MANAGEMENT LLC Bought 2.4 Million shares of Celgene Corp
DEUTSCHE BANK INVESTMENT MANAGEM... Bought 1.1 Million shares of Celgene Corp
WELLS CAPITAL MANAGEMENT, INC. Bought 1.1 Million shares of Celgene Corp